Takeaways from this week in optometry: September 8- September 12
Catch up on the top stories in optometry during the week of September 8-September 12.
Long-term atropine use to treat myopia associated with increased risk of ocular complication in schoolchildren in Taiwan
Myopia treatment trends outlined in The Vision Council's recent report
A total of 293 optometrists, practice owners, and managers were involved in the survey.
New study examines soft drusen regression without atrophy and drusen ooze
Researchers conducted this study to determine how often and why spontaneous soft drusen regresses without atrophy in patients who had intermediate or atrophic age-related macular degeneration.
University of Houston researchers receive $3.6 million to examine retinal diseases
Researchers will investigate a gene in the eye that is crucial for normal vision, but can cause retinal diseases when mutated that often lead to blindness.
Alcon announces launch of personalized LASIK treatment in the US and Canada
wavelight plus was first launched in China, with several European and Asia-Pacific markets following suit.
American Academy of Optometry 2025 award recipients in the books
Award winners will be recognized during the Academy 2025 meeting in Boston, Massachusetts, running from October 8 to 11.
New study demonstrates Xiidra's efficacy in alleviating discomfort in symptomatic contact lens wearers
Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease (DED) and works by targeting the source of inflammation.
Opus Genetics doses first patient in phase 3 LYNX-3 trial evaluating phentolamine ophthalmic solution 0.75%
The trial will evaluate the solution in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision.
Bausch + Lomb launches ASANA gas permeable lenses in the US
The lens portfolio includes spherical, aspheric, toric, multifocal, multifocal toric, reverse geometry, and keratoconic contact lenses.
From discussion to decision: Educating patients on IOL expectations for better outcomes
Takeaways from this week in optometry: September 1 - September 5
Catch up on the top stories in optometry during the week of September 1-September 5.
The #SeeWhatMatters campaign and the importance of ocular research
Dan Ignaszewski, executive director of the Alliance for Eye and Vision Research and the National Alliance for Eye and Vision Research, provides insight into the new campaign and how to get involved.
GLP-1RAs associated with reduction in uveitis development risk in new study
Findings from the retrospective, observational study support the potential anti-inflammatory benefits of the drug class.
First, next, last: Timing of specialty lenses for patients with keratoconus
Calista Ming, OD, FAAO, FSLS, provides 3 cases of how to fit specialty lenses at the right time for patients.
Outlook Therapeutics requests Type A meeting with FDA following second CRL for ONS-5010
Outlook Therapeutics seeks FDA clarity on ONS-5010 after a complete response letter, aiming to address efficacy concerns for wet AMD treatment.
The optometric community reflects on the late Richard Hopping, OD, and his legacy
The optometric giant recently passed away at the age of 97.
New World Medical launches new nonvalved glaucoma drainage device
The company stated that the distinguishing feature of the new Ahmed ClearPath ST is its smaller tube lumen.
AAOpt 2025: The Women's Health Special Interest Group to take the stage
Naureen Haroon, OD, MPH, FAAO, founder of the newly formed WHSIG, said the group's primary aim is to educate the optometric community about why certain eye conditions disproportionately affect women.
Keeping up with dry eye: Approaches to treatment plans, patient education, and clinical developments
Dry eye specialists weigh in on what role dry eye plays in their practices.
